rs111033257
Orientation | plus |
Stabilized | plus |
Geno | Mag | Summary |
---|---|---|
(G;G) | 0 | common in clinvar |
Make rs111033257(A;A) |
Make rs111033257(A;G) |
Reference | GRCh38 38.1/141 |
Chromosome | 7 |
Position | 107700162 |
Gene | SLC26A4 |
is a | snp |
is | mentioned by |
dbSNP | rs111033257 |
dbSNP (classic) | rs111033257 |
ClinGen | rs111033257 |
ebi | rs111033257 |
HLI | rs111033257 |
Exac | rs111033257 |
Gnomad | rs111033257 |
Varsome | rs111033257 |
LitVar | rs111033257 |
Map | rs111033257 |
PheGenI | rs111033257 |
Biobank | rs111033257 |
1000 genomes | rs111033257 |
hgdp | rs111033257 |
ensembl | rs111033257 |
geneview | rs111033257 |
scholar | rs111033257 |
rs111033257 | |
pharmgkb | rs111033257 |
gwascentral | rs111033257 |
openSNP | rs111033257 |
23andMe | rs111033257 |
SNPshot | rs111033257 |
SNPdbe | rs111033257 |
MSV3d | rs111033257 |
GWAS Ctlg | rs111033257 |
Max Magnitude | 0 |
ClinVar | |
---|---|
Risk | rs111033257(A;A) |
Alt | rs111033257(A;A) |
Reference | Rs111033257(G;G) |
Significance | Probable-Pathogenic |
Disease | Enlarged vestibular aqueduct syndrome Pendred's syndrome |
Variation | info |
Gene | SLC26A4 |
CLNDBN | Enlarged vestibular aqueduct syndrome Pendred's syndrome |
Reversed | 0 |
HGVS | NC_000007.13:g.107340607G>A |
CLNSRC | UniProtKB (protein) |
CLNACC | RCV000036454.2, |
[PMID 192049] Substance P and primary afferent transmission.
[PMID 9618166] Two frequent missense mutations in Pendred syndrome.
[PMID 14508505] Distribution and frequencies of PDS (SLC26A4) mutations in Pendred syndrome and nonsyndromic hearing loss associated with enlarged vestibular aqueduct: a unique spectrum of mutations in Japanese.
[PMID 15689455] SLC26A4/PDS genotype-phenotype correlation in hearing loss with enlargement of the vestibular aqueduct (EVA): evidence that Pendred syndrome and non-syndromic EVA are distinct clinical and genetic entities.
[PMID 15720248] Pathogenetics of the human SLC26 transporters.
[PMID 16950989] Simultaneous multigene mutation detection in patients with sensorineural hearing loss through a novel diagnostic microarray: a new approach for newborn screening follow-up.